Cell Source annual free cash flow
2013
2014
Cell Source reported −$3.1M in free cash flow for fiscal 2014, a decrease of $4.0M from the previous fiscal year.
View full Cell Source company overview| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2014 | 2014-12-31 | −$3.1M | −$4.0M | — | — |
| 2013 | 2013-12-31 | $894,000 | — | — | — |
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q3 2014 | 2014-09-30 | $785,000 | — | — | — |
| Q3 2013 | 2013-09-30 | $19,000 | — | — | — |
Cell Source's latest reported quarter, Q3 2014, generated $785,000 in free cash flow.
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Cell Source filings at SEC.gov ↗